# Movement Disorders

This is a subcategory of Central Nervous System (CNS) Agents.

## Length of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval?

Acceptable reasons include:

- Allergy to all medications not requiring prior approval

- Contraindication to or drug-to-drug interaction with medications not requiring prior approval.

- History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Criteria

### Tardive Dyskinesia

Additional Criteria for the Treatment of Tardive Dyskinesia

- Prescribed by a Neurologist or Psychiatrist

- Ingrezza is ONLY indicated for the treatment of Tardive Dyskinesia

### Huntington's Disease

Additional Criteria for Austedo for the Treatment of Huntington's Disease

- The patient must have a failure to respond to maximally tolerated dose of tetrabenazine

Austedo quantity limit of 4 tablets per day

## Formulary

Central Nervous System (CNS) Agents: Movement Disorders

### Preferred

| Preferred        |
| :--------------- |
| Austedo PA       |
| Ingrezza PA      |
| Tetrabenazine PA |

### Non-Preferred

| Non-Preferred |
| :------------ |
|               |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=37)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=16)
